Recent Finacing
Recent Raise
Cerevance is a clinical-stage biopharmaceutical company developing cell type-specific targeted therapies for neurodegenerative diseases and obesity.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Cerevance.
